# Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence

> **NCT00817895** · NA · COMPLETED · sponsor: **Eastern Hepatobiliary Surgery Hospital** · enrollment: 150 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** sustained released 5-FU and sustained released cisplatin
- **DRUG:** sustained released 5-FU
- **PROCEDURE:** TACE

## Key facts

- **NCT ID:** NCT00817895
- **Lead sponsor:** Eastern Hepatobiliary Surgery Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-12
- **Final completion:** 2010-12
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2016-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00817895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00817895, "Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00817895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*